Cara therapeutics stock price history
Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates. Cara (CARA) delivered earnings and revenue surprises of 1.61% and -19.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? Don't Get Greedy With Cara Therapeutics, Inc. Stock | The ... Don't Get Greedy With Cara Therapeutics, Inc. Stock History lessons. Cara's share price plunged on news that an oral version of CR-845 didn't significantly reduce pain in patients compared Cara Therapeutics - Stock Split History | CARA | MacroTrends
CARA Stock Quote - Cara Therapeutics, Inc. Common Stock ...
Cara Therapeutics, Inc. (CARA) stock price, quote, history ... Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates. Cara (CARA) delivered earnings and revenue surprises of 1.61% and -19.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? Don't Get Greedy With Cara Therapeutics, Inc. Stock | The ... Don't Get Greedy With Cara Therapeutics, Inc. Stock History lessons. Cara's share price plunged on news that an oral version of CR-845 didn't significantly reduce pain in patients compared Cara Therapeutics - Stock Split History | CARA | MacroTrends Stock split history for Cara Therapeutics since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.
In depth view into CARA (Cara Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Cara Therapeutics (CARA) Stock Price Chart - History ... Cara Therapeutics live price charts and stock performance over time. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Search for a market's symbol or name (AAPL or Apple) or an investor's name Cara Therapeutics live price charts and stock performance over time. Use technical analysis
CARA | Cara Therapeutics Inc. Stock Price & News - WSJ
CARA Stock Price & Charts | Cara Therapeutics In depth view into CARA (Cara Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.
6 Feb 2019 An examination of Cara Therapeutics stock, its rivals, whether it's shares have gained 23.2% whereas the S&P 500 has gained 1.4% (see chart). Cara, so it believes it will benefit both from distribution and the stock price.
6 Feb 2019 An examination of Cara Therapeutics stock, its rivals, whether it's shares have gained 23.2% whereas the S&P 500 has gained 1.4% (see chart). Cara, so it believes it will benefit both from distribution and the stock price. Cara Therapeutics, Inc. (CARA) Stock Price, Quote, History ... Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing. Cara Therapeutics, Inc. (CARA) Stock Historical Prices ... 102 rows · Discover historical prices for CARA stock on Yahoo Finance. View daily, weekly or monthly …
Cara Therapeutics historical price data and CARA charts. Free real-time prices, trades, and chat. Cara Therapeutics (CARA) share price, charts, trades & the UK's most popular discussion forums. CARA: Cara Therapeutics, Inc. - Price & Consenus Chart ... CARA: Cara Therapeutics, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Cara Therapeutics, Inc. from Zacks Investment Research Cara Therapeutics, Inc. (CARA) stock price, quote, history ... Cara (CARA) delivered earnings and revenue surprises of 1.61% and -19.13%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock? STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a loss of $28.6 million in its fourth Historical Data for Cara Therapeutics Inc. (CARA) RT Real-Time, RTB Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN Real-Time NASDAQ Price/Quote; not sourced from all markets, EOD End Of Day, PD Previous Day. H Halted, R Restriction started today, r Restriction carried over from prior day .